JATT Acquisition Corp’s Lock-Up Period Set To End on October 14th (NYSE:JATT)

JATT Acquisition’s (NYSE:JATT) lock-up period is set to expire on Wednesday, October 14th. JATT Acquisition had issued 6,000,000 shares in its IPO on April 17th. The total size of the offering was $60,000,000 based on an initial share price of $10.00. After the end of JATT Acquisition’s lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

JATT Acquisition Price Performance

NYSE JATT opened at $10.53 on Friday. The stock’s fifty day moving average is $12.09 and its two-hundred day moving average is $10.62. JATT Acquisition has a fifty-two week low of $9.99 and a fifty-two week high of $23.76.

Institutional Investors Weigh In On JATT Acquisition

A hedge fund recently bought a new position in JATT Acquisition stock. Spruce Street Capital LP bought a new position in shares of JATT Acquisition Corp (NYSE:JATT) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 160,000 shares of the company’s stock, valued at approximately $1,817,600. Spruce Street Capital LP owned 1.99% of JATT Acquisition at the end of the most recent reporting period. 47.97% of the stock is currently owned by institutional investors and hedge funds.

JATT Acquisition Company Profile

JATT Acquisition Corp. was a special purpose acquisition company formed to identify and complete a business combination with a company in the healthcare, biotechnology, pharmaceutical or medical-device sectors. As a blank-check company, it did not operate a commercial business or offer products and services of its own before completing a transaction.

JATT announced a business combination with Zura Bio Limited, a biotechnology company developing medicines for immune-mediated diseases. The transaction was completed in 2023, after which the combined company operated under the Zura Bio name and JATT Acquisition Corp.